BACKGROUNDS/AIMS: To compare the clinical outcomes of intraoperative radiofrequency ablation (RFA) and non-anatomical hepatic resection (NAHR) for @entity157 ( @entity157 ). METHODS: From February 2007 to January 2015, clinical outcomes of thirty four @entity1 with @entity157 receiving RFA or NAHR were compared, retrospectively. RESULTS: There was no difference of @entity1 and @entity5 characteristic between the two groups that received RFA or NAHR. The 1, 2, and 3-year recurrence rates following RFA were 32.2%, 32.2% and 59.3% respectively, and 6.7%, 33.3% and 33.3% following NAHR respectively (p=0.287). The 1, 2 and 3-year @entity1349 ( @entity1349 ) rates following RFA were 100%, 88.9% and 76.2% respectively, and 100%, 85.6% and 85.6%, respectively, following NAHR (p=0.869). We did not find a definite statistical difference in recurrence rate and @entity1349 rate between the two groups. In the multivariate analysis, number of @entity5 was an independent prognostic factor for recurrence and albumin was an independent prognostic factor for @entity1349 . CONCLUSIONS: We recommend non-anatomical hepatic resection rather than intraoperative RFA in small sized @entity157 , due to a higher recurrence rate in intraoperative RFA. Intraoperative RFA was inferior to non-anatomical hepatic resection in terms of recurrence rate. We need to select the optimal treatment considering liver function and possibility of recurrence.

Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for XXXX : short-term result.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'small hepatocellular carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity157 :: (MESH:D006528,Disease) :: ['small hepatocellular carcinoma']
